Two-Drug Regimens for HIV—Current Evidence, Research Gaps and Future Challenges

During the last 30 years, antiretroviral treatment (ART) for human immunodeficiency virus (HIV) infection has been continuously evolving. Since 1996, three-drug regimens (3DR) have been standard-of-care for HIV treatment and are based on a protease inhibitor (PI) or a non-nucleoside reverse transcri...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-González, Alexandre, Suárez-García, Inés, Ocampo, Antonio, Poveda, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880461/
https://www.ncbi.nlm.nih.gov/pubmed/35208887
http://dx.doi.org/10.3390/microorganisms10020433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880461/
https://www.ncbi.nlm.nih.gov/pubmed/35208887
http://dx.doi.org/10.3390/microorganisms10020433

Ejemplares similares